(Q44071669)

29 November 2017

Low-dose interferon-alpha treatment for feline immunodeficiency virus infection (English)

1 reference

feline immunodeficiency virus

29 November 2017

object named as

feline immunodeficiency virus

1 reference

Pedretti E

1

1 reference

29 November 2017

Passeri B

2

1 reference

29 November 2017

Amadori M

3

1 reference

29 November 2017

Isola P

4

1 reference

29 November 2017

Di Pede P

5

1 reference

29 November 2017

Telera A

6

1 reference

29 November 2017

Vescovini R

7

1 reference

29 November 2017

Quintavalla F

8

1 reference

29 November 2017

Pistello M

9

1 reference

29 November 2017

19 September 2005

1 reference

Veterinary Immunology and Immunopathology

29 November 2017

1 reference

29 November 2017

109

1 reference

29 November 2017

3-4

1 reference

29 November 2017

245-254

1 reference

Effects of IFN-alpha on the inflammatory response of swine leukocytes to bacterial endotoxin.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

The neglected role of type I interferon in the T-cell response: implications for its clinical use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Systemic effects of interferons after oral administration in animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Zidovudine toxicity to cats infected with feline leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Long-term clinical observations on feline immunodeficiency virus infected asymptomatic carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Feline immunodeficiency virus: a concise review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Oral administration of interferon-alpha induces a transient decline in oral mucosal immunoglobulins and an increase in interleukin-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Effects of interferon alpha (INF-alpha) therapy on peripheral blood lymphocyte subsets from FIV and FeLV naturally infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Immunohistochemical localization of feline immunodeficiency virus using native species antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Oral cytokine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Studies on the suitability of alpha-hybrid interferon application in cattle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

Structure-activity of type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

FIV infection of the domestic cat: an animal model for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.020

10.1016/J.VETIMM.2005.08.020

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference